More Globe Newswire

View Older Stories View Newer Stories

Aug 8, 2025 04:30PM Jeff Harsh named new Chief Operating Officer of Advantage Solutions Branded Services business segment
Aug 8, 2025 04:30PM Paul Mueller Company Announces Quarterly Cash Dividend
Aug 8, 2025 04:29PM CNL STRATEGIC CAPITAL ANNOUNCES OPERATING RESULTS FOR SECOND QUARTER 2025
Aug 8, 2025 04:30PM Alamos Gold Announces Filing of Base Shelf Prospectus
Aug 8, 2025 04:30PM Faraday Future Announces the Upcoming Special Meeting to Enable Rapid Execution of the Second Chapter of the Bridge Strategy and Adhere to Prudent Issuance Commitment Through Key Proposals
Aug 8, 2025 04:30PM Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 8, 2025 04:29PM CNL STRATEGIC CAPITAL ANNOUNCES OPERATING RESULTS FOR SECOND QUARTER 2025
Aug 8, 2025 04:26PM Banco Comercial Português, S.A. informs about Interim report on the transactions conducted under the Share Buy-Back Programme
Aug 8, 2025 04:24PM #1 Best Selling Author, Robert J. Smith, MFA Unveils New Groundbreaking Business Guide
Aug 8, 2025 04:20PM Barnes & Noble Education Receives NYSE Notice Regarding Delayed 10-K Filing
Aug 8, 2025 04:20PM Barnes & Noble Education Receives NYSE Notice Regarding Delayed 10-K Filing
Aug 8, 2025 04:15PM NI Holdings, Inc. Reports Results for Second Quarter Ended June 30, 2025
Aug 8, 2025 04:15PM Calidi Biotherapeutics Reports Second Quarter 2025 Financial Results and Recent Operational Highlights
Aug 8, 2025 04:10PM Westwood Holdings Group, Inc. Reports Second Quarter 2025 Results
Aug 8, 2025 04:10PM Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea
Aug 8, 2025 04:05PM Surrozen Reports Second Quarter 2025 Financial Results and Provides Business Update
Aug 8, 2025 04:05PM Monroe Capital Corporation Schedules Second Quarter 2025 Earnings Release
Aug 8, 2025 04:05PM Arvinas Announces FDA Acceptance of the New Drug Application for Vepdegestrant for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer
Aug 8, 2025 04:05PM Entera Bio Announces Second Quarter 2025 Financial Results and Business Updates
Aug 8, 2025 04:05PM Commerce to Present at Upcoming Investor Conference
Aug 8, 2025 04:05PM Hyperion Defi to Report Second Quarter 2025 Results on Wednesday, August 13, 2025
Aug 8, 2025 04:05PM Capital Clean Energy Carriers Corp. Announces Annual Meeting of Shareholders
Aug 8, 2025 04:05PM Amwell makes grant to new employees under inducement plan
Aug 8, 2025 04:05PM Femasys Announces Second Quarter Financial Results for 2025
Aug 8, 2025 04:05PM Phunware Reports Second Quarter 2025 Financial Results
Aug 8, 2025 04:05PM Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 8, 2025 04:03PM Heartland Physio Unveils The R.E.A.L. Recovery Experience for Singapore’s Active Professionals
Aug 8, 2025 04:03PM NurExone’s Exosomes Show Stronger Healing Potential Than Industry Standard
Aug 8, 2025 04:01PM UPDATE – Currenc Group's Founder and Executive Chairman to Convert $54.6 Million in Loans to Equity
Aug 8, 2025 04:01PM UPDATE – Currenc Group's Founder and Executive Chairman to Convert $54.6 Million in Loans to Equity
Aug 8, 2025 04:01PM Compass Therapeutics to Present Second Quarter Financial Results and Provide Business Update on August 11, 2025
Aug 8, 2025 04:00PM IPG Chicago Facility Achieves TRUE Gold Zero Waste Certification
Aug 8, 2025 04:00PM Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 8, 2025 04:00PM Brookfield Property Partners Declares Quarterly Dividends on Listed Preferred Units
Aug 8, 2025 04:00PM Outdoor Holding Company Reports First Quarter Fiscal 2026 Financial Results
Aug 8, 2025 03:46PM Final Countdown: San Francisco Set to Host B2B’s Boldest Voices at Marketers Connect
Aug 8, 2025 03:45PM Secret DUO Now Available at South Jersey Skin Care
Aug 8, 2025 03:30PM USX Cyber® Launches Integrated Application Control Module in GUARDIENT® Platform
Aug 8, 2025 03:28PM Saputo Announces Election of Directors
Aug 8, 2025 03:25PM U.S. FDA grants accelerated approval to Boehringer’s HERNEXEOS® as first orally administered targeted therapy for previously treated patients with HER2-mutant advanced NSCLC
Aug 8, 2025 03:25PM U.S. FDA grants accelerated approval to Boehringer’s HERNEXEOS® as first orally administered targeted therapy for previously treated patients with HER2-mutant advanced NSCLC
Aug 8, 2025 03:16PM Nang Robot Expands Product Line With New 3.3 Litre Tanks With Delivery Across Melbourne
Aug 8, 2025 03:16PM Real Estate Meets Fintech: Shakib Uddin’s Global Trade Bangladesh Launches New Dubai Platform
Aug 8, 2025 03:09PM New Toll Brothers Model Home Opens in Bellevue, Washington
Aug 8, 2025 02:54PM Bringing Advanced Vascular Diagnostics to the Western US with the SmartVascular Dx™ Test
Aug 8, 2025 02:45PM American Rebel Light Beer is Delivering Powerful Sales Performance and Increasing Market Share Momentum at its Inaugural Debut at the Knoxville Nationals, Approximately 25,000 Fans Expected Saturday
Aug 8, 2025 02:10PM FAT Brands Opens First Co-Branded Round Table Pizza and Fatburger in California
Aug 8, 2025 02:05PM U.S. Global Investors Launches Its Smart Beta 2.0 SEA ETF on the Mexican Stock Exchange, Joining JETS and GOAU
Aug 8, 2025 01:35PM End of Day Message
Aug 8, 2025 01:32PM UPDATE - Labrynth Launches the Red Tape Index to Help America Build Smarter, Faster
View Newer Stories View Older Stories